Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Imoto

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chemical & Pharmaceutical Bulletin|February 11, 2003
Studies on non-thiazolidinedione antidiabetic agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agentsHiroshi Imoto, Yasuo Sugiyama, Hiroyuki Kimura, et al.
Microscopy (Oxford, England)|April 16, 2025
Ultra-Low Accelerating Voltage Scanning Electron Microscopy with Multiple Imaging DetectorsKaoru Sato, Masayasu Nagoshi, Takaya Nakamura, et al.
Journal of the American Chemical Society|February 16, 2012
Destabilizing domains derived from the human estrogen receptorYusuke Miyazaki, Hiroshi Imoto, Ling-chun Chen, et al.
Chemical & Pharmaceutical Bulletin|October 10, 2002
Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivativesHiroshi Imoto, Eikoh Imamiya, Yu Momose, et al.
European Journal of Pharmacology|June 29, 2004
A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypesJunichi Sakamoto, Hiroyuki Kimura, Shinji Moriyama, et al.
Chemical & Pharmaceutical Bulletin|January 8, 2004
Studies on non-thiazolidinedione antidiabetic agents. 3. Preparation and biological activity of the metabolites of TAK-559Hiroshi Imoto, Mitsuharu Matsumoto, Hiroyuki Odaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Visualizing cellular interactions with a generalized proximity reporterMark A Sellmyer, Laura Bronsart, Hiroshi Imoto, et al.
Chemical & Pharmaceutical Bulletin|July 17, 2004
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moietyMasaki Seto, Yoshio Aramaki, Hiroshi Imoto, et al.
ACS Omega|December 21, 2020
Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug DesignIkuo Fujimori, Takeshi Wakabayashi, Morio Murakami, et al.
Bioorganic & Medicinal Chemistry|February 11, 2014
Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonistsKenjiro Sato, Hiromichi Sugimoto, Kentaro Rikimaru, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemical & Pharmaceutical Bulletin|February 11, 2003
Studies on non-thiazolidinedione antidiabetic agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agentsHiroshi Imoto, Yasuo Sugiyama, Hiroyuki Kimura, et al.
Microscopy (Oxford, England)|April 16, 2025
Ultra-Low Accelerating Voltage Scanning Electron Microscopy with Multiple Imaging DetectorsKaoru Sato, Masayasu Nagoshi, Takaya Nakamura, et al.
Journal of the American Chemical Society|February 16, 2012
Destabilizing domains derived from the human estrogen receptorYusuke Miyazaki, Hiroshi Imoto, Ling-chun Chen, et al.
Chemical & Pharmaceutical Bulletin|October 10, 2002
Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivativesHiroshi Imoto, Eikoh Imamiya, Yu Momose, et al.
European Journal of Pharmacology|June 29, 2004
A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypesJunichi Sakamoto, Hiroyuki Kimura, Shinji Moriyama, et al.
Chemical & Pharmaceutical Bulletin|January 8, 2004
Studies on non-thiazolidinedione antidiabetic agents. 3. Preparation and biological activity of the metabolites of TAK-559Hiroshi Imoto, Mitsuharu Matsumoto, Hiroyuki Odaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Visualizing cellular interactions with a generalized proximity reporterMark A Sellmyer, Laura Bronsart, Hiroshi Imoto, et al.
Chemical & Pharmaceutical Bulletin|July 17, 2004
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moietyMasaki Seto, Yoshio Aramaki, Hiroshi Imoto, et al.
ACS Omega|December 21, 2020
Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug DesignIkuo Fujimori, Takeshi Wakabayashi, Morio Murakami, et al.
Bioorganic & Medicinal Chemistry|February 11, 2014
Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonistsKenjiro Sato, Hiromichi Sugimoto, Kentaro Rikimaru, et al.
Pageof 2